STOCK TITAN

[1-Z] BIO-PATH HOLDINGS, INC. SEC Filing

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
1-Z

Rhea-AI Filing Summary

Analyzing...
schemaVersion:

1-Z: Filer Information

Issuer CIK
Issuer CCC
File Number
Is this filing by a successor company pursuant to Rule 257(b)(5) resulting from a merger or other business combination? Yes No
Successor File Number
Is this a LIVE or TEST Filing? LIVE TEST
Is this an electronic copy of an official filing submitted in paper format?
Would you like a Return Copy?

Submission Contact Information

Name
Phone
E-Mail Address
Notify via Filing Website only?

1-Z: PRELIMINARY INFORMATION

Exact name of issuer as specified in the issuer's charter

Address of Principal Executive Offices
Address 1

Address 2

City

State/Country

Mailing Zip/ Postal Code

Phone

Commission File Number(s)

1-Z: PART I Summary Information Regarding the Offering and Proceeds

Summary Information

Date of qualification of the offering statement

Date of commencement of the offering

Amount of securities qualified to be sold in the offering

Amount of securities sold in the offering

Price per security:

The portion of aggregate sales attributable to securities sold on behalf of the issuer

The portion of aggregate sales attributable to securities sold on behalf of selling securityholders:

Fees in connection with this offering and names of service providers.

Underwriters - Name of Service Provider Underwriters - Fees
Sales Commissions - Name of Service Provider Sales Commissions - Fee
Finders' Fees - Name of Service Provider Finders' Fees - Fees
Accounting or Audit - Name of Service Provider Accounting or Audit - Fees
Legal - Name of Service Provider Legal - Fees
Promoters - Name of Service Provider Promoters - Fees
Blue Sky Compliance - Name of Service Provider Blue Sky Compliance - Fees
CRD Number of any broker or dealer listed

Net proceeds to the issuer

Clarification of responses (if necessary):

1-Z: PART II Certification of Suspension of Duty to File Reports

Certification

Title of each class of securities covered by this Form

Commission File Number(s)

Approximate number of holders of record as of the certification date

1-Z: Signature

Signature

Pursuant to the requirements of Regulation A,

Cik

(Name of issuer as specified in charter)

certifies that it meets all of the conditions for termination of Regulation A reporting specified in Rule 257(d) and that there are no classes of securities other than those that are the subject to this Form 1-Z regarding which the issuer has Regulation A reporting obligations.

(Name of issuer as specified in charter)

Has caused this certification to be signed on its behalf by the undersigned duly authorized person.

By

Date

Title

Instructions: This Part II of Form 1-Z is required by Rule 257(d) of Regulation A. An officer of the issuer or any other duly authorized person may sign, and must do so by typed signature. The name and title of the person signing the form must be typed or printed under the signature. The signatory to the filing must also manually sign a signature page or other document authenticating, acknowledging or otherwise adopting his or her signature that appears in the filing. Such document must be executed before or at the time the filing is made and must be retained by the issuer for a period of five years. Upon request, the issuer must furnish to the Commission or its staff a copy of any or all documents retained pursuant to this instruction.

Bio-Path Hldgs Inc

OTC:BPTH

BPTH Rankings

BPTH Latest News

BPTH Latest SEC Filings

BPTH Stock Data

4.66M
9.24M
Biotechnology
Pharmaceutical Preparations
Link
United States
BELLAIRE